Literature DB >> 29060173

Relationship between heart rate excursion and apnea duration in patients with Obstructive Sleep Apnea.

Jordi Sola-Soler, Beatriz F Giraldo, Jose Antonio Fiz, Raimon Jane.   

Abstract

Obstructive Sleep Apnea (OSA) is a sleep disorder with a high prevalence in the general population. It is a risk factor for many cardiovascular diseases, and an independent risk factor for cerebrovascular diseases such as stroke. After an apnea episode, both arterial blood pressure and cerebral blood flow velocity change in function of the apnea duration (AD). We hypothesized that the relative excursion in heart rate (AHR), defined as the percentage difference between the maximum and the minimum heart rate values associated to an obstructive apnea event, is also related to AD. In this work we studied the relationship between apnea-related AHR and AD in a population of eight patients with severe OSA. AHR and AD showed a moderate but statistically significant correlation (p <; 0.0001) in a total of 1454 obstructive apneas analyzed. The average heart rate excursion for apneas with AD ≥ 30s (ΔHR = 31.29 ± 6.64%) was significantly greater (p = 0.0002) than for apneas with AD ∈ [10,20)s (ΔHR = 18.14±3.08%). We also observed that patients with similar Apnea-Hypopnea Index (AHI) may exhibit remarkably different distributions of AHR and AD, and that patients with a high AHI need not have a higher average AHR than others with a lower severity index. We conclude that the overall apnea-induced heart rate excursion is partially explained by the duration of apnoeic episodes, and it may be a simple measure of the cardiovascular stress associated with OSA that is not directly reflected in the AHI.

Entities:  

Mesh:

Year:  2017        PMID: 29060173     DOI: 10.1109/EMBC.2017.8037129

Source DB:  PubMed          Journal:  Conf Proc IEEE Eng Med Biol Soc        ISSN: 1557-170X


  1 in total

1.  Longer apneas and hypopneas are associated with greater ultra-short-term HRV in obstructive sleep apnea.

Authors:  Salla Hietakoste; Henri Korkalainen; Samu Kainulainen; Saara Sillanmäki; Sami Nikkonen; Sami Myllymaa; Brett Duce; Juha Töyräs; Timo Leppänen
Journal:  Sci Rep       Date:  2020-12-09       Impact factor: 4.996

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.